Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of polysaccharide in medicament for treating or preventing primary cerebral hemorrhage

A kind of bitter gourd polysaccharide, primary technology, applied in the direction of drug combination, cardiovascular system diseases, anti-toxins, etc., can solve the problems of unsatisfactory clinical effect, achieve the change of high disability rate and fatality rate, and improve cure The effect on rate and survival

Inactive Publication Date: 2012-07-04
XUZHOU MEDICAL COLLEGE
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, there is still no data to support the effective use of bitter melon polysaccharides in the treatment of cerebral hemorrhage, an acute and spontaneous blood spillage into the brain parenchyma, which is the cause of disability and death worldwide. Restoring cerebral blood flow supply and enhancing neuron protection are two strategies for the treatment of ischemic cerebral hemorrhage, but the clinical effect of these two strategies is not satisfactory so far.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of polysaccharide in medicament for treating or preventing primary cerebral hemorrhage
  • Application of polysaccharide in medicament for treating or preventing primary cerebral hemorrhage
  • Application of polysaccharide in medicament for treating or preventing primary cerebral hemorrhage

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] combine figure 1 , the present invention carries out in vivo experiment of bitter gourd polysaccharide on SD rat cerebral hemorrhage model, and establishes rat caudate nucleus hemorrhage model and control model. After intraperitoneal anesthesia with 100g / L chloral hydrate (2mL / kg), the head and thigh were prepared, and the skin of the right thigh was disinfected with complex iodine. The incision was 10mm long, and the femoral artery was peeled off to expose it. 2 mL of autologous blood was extracted from the femoral artery and anticoagulated with heparin (50u / mL). Centrifuge at 3000r / min for 10min, discard the upper layer of plasma, white blood cells and platelets, wash the red blood cells with pre-cooled normal saline for 3 times, transfer them to EP tubes and centrifuge, place them in a liquid nitrogen tank at -196°C for 5min, and thaw them completely in a 37°C water bath. Make autologous hemoglobin. The rats were fixed on the stereotaxic instrument, the skin was in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to novel application of the medical effect of polysaccharide, in particular to application of polysaccharide in a medicament for treating or preventing primary cerebral hemorrhage. An SD (Sprague Dawley) rat cerebral hemorrhage model is used as an experimental material, and the polysaccharide is used for treating an SD rat with primary cerebral hemorrhage neuronal damage, no matter the drug administration is carried out before or after the model, the polysaccharide has the effect of reducing encephaledema (BBB, brain blood barrier) in the cerebral hemorrhage model; drug administration before hemorrhage indicates that the inhibition ratios to brain water content (BBB) are respectively 10.4 percent and 13.3 percent if dosages are 60 and 100mg / kg, and the prevention effect is good; and drug administration before hemorrhage indicates that the inhibition ratios to the brain water content (BBB) are respectively 9.5 percent and 12 percent if dosages are 60 and 100mg / kg. The remarkable medical effect of the polysaccharide in cerebral hemorrhage treatment before clinical application indicates the clinical treatment practicability of polysaccharide in cerebral hemorrhage treatment. The polysaccharide can be used as a prevention medicament and a treatment medicament to improve the cure rate and survival rate of cerebral hemorrhage and has good treatment effect.

Description

technical field [0001] The invention relates to a new medicinal application of bitter gourd polysaccharide, in particular to the application of bitter gourd polysaccharide in medicine for treating or preventing primary cerebral hemorrhage. Background technique [0002] Bitter melon (Momordica charantia, MC), also known as bitter gourd, brocade litchi, epilepsy melon, is a plant of the genus Momordica cucurbitaceae. Bitter gourd is a famous folk Chinese herbal medicine. The medicinal record of bitter gourd was first recorded in "Southern Yunnan Materia Medica" in the Ming Dynasty, and there were many records thereafter. "Compendium of Materia Medica" says: "Remove evil heat, relieve fatigue, clear heart and eyesight, replenish qi and strengthen yang". The research on the medicinal value of bitter melon has made important progress at home and abroad, and the research on the active ingredients of bitter melon is still in progress. [0003] Document 1: H Okabe, Y Miyahara, T ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/715A61P9/10A61P39/06
Inventor 齐素华崔桂云巩娟娟倪小宇
Owner XUZHOU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products